Original Title: Sistema flash para monitoreo de glucemia en pacientes con diabetes mellitus

Authors' recommendations: "Conclusions Moderate-quality evidence shows that flash glucose monitoring in patients with diabetes mellitus receiving intensive insulin therapy probably yields a considerable net benefit, since it reduces the number of severe hypoglycemic events and hospitalizations, improves the quality of life of individuals, reduces the number of events and time in hypoglycemia, and also improves metabolic control compared to blood glucose self-monitoring. No studies have been found relating the use of the flash device for metabolic control of diabetes with long-term disease systemic complications, such as peripheral artery disease, retinopathy, and cardiovascular and cerebrovascular conditions. Most clinical practice guidelines developed for this technology recommend including this device for glucose monitoring in patients with diabetes mellitus, since it has shown it improves glucose control, reduces the rate of hypoglycemic events and increases satisfaction and quality of life of patients receiving intensive insulin therapy. The flash glucose monitoring system is not explicitly covered by health funders in most Latin American countries, unlike high-income countries where it is covered. In addition, it is not covered by the Mandatory Medical Program and is not eligible for reimbursement through Argentina’s Unique Reimbursement System for Disease Management. From the economic point of view, this technology has proven to be cost-effective in high-income countries. To date, there are no cost-effective studies performed in Argentina or in low-to-mid income countries. However, a budget impact analysis in Argentina suggests that including this technology could be associated with net savings for private funders and social security funds."

Project Status: Completed

URL for project: https://ets.iecs.org.ar/publication/2103

Year Published: 2023

URL for published report: https://ets.iecs.org.ar/publication/2103

English language abstract: An English language summary is available

Publication Type: Not Assigned

Country: Argentina

Organisation Name: Institute for Clinical Effectiveness and Health Policy

Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA

Contact Name: info@iecs.org.ar

Contact Email: info@iecs.org.ar

Copyright: <p>Institute for Clinical Effectiveness and Health Policy (IECS)</p>